Moore Erika M, Maestas David R, Cherry Chris C, Garcia Jordan A, Comeau Hannah Y, Davenport Huyer Locke, Kelly Sean H, Peña Alexis N, Blosser Richard L, Rosson Gedge D, Elisseeff Jennifer H
Department of Materials Science and Engineering, University of Florida, Gainesville, FL, USA.
Translational Tissue Engineering Center, Wilmer Eye Institute and the Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA.
Sci Adv. 2021 Dec 3;7(49):eabj5830. doi: 10.1126/sciadv.abj5830. Epub 2021 Dec 1.
B cells are an adaptive immune target of biomaterials development in vaccine research but, despite their role in wound healing, have not been extensively studied in regenerative medicine. To probe the role of B cells in biomaterial scaffold response, we evaluated the B cell response to biomaterial materials implanted in a muscle wound using a biological extracellular matrix (ECM), as a reference for a naturally derived material, and synthetic polyester polycaprolactone (PCL), as a reference for a synthetic material. In the local muscle tissue, small numbers of B cells are present in response to tissue injury and biomaterial implantation. The ECM materials induced mature B cells in lymph nodes and antigen presentation in the spleen. The synthetic PCL implants resulted in prolonged B cell presence in the wound and induced an antigen-presenting phenotype. In summary, the adaptive B cell immune response to biomaterial induces local, regional, and systemic immunological changes.
在疫苗研究中,B细胞是生物材料开发的适应性免疫靶点,但尽管它们在伤口愈合中发挥作用,在再生医学中却尚未得到广泛研究。为了探究B细胞在生物材料支架反应中的作用,我们使用生物细胞外基质(ECM)作为天然衍生材料的参考,以及合成聚酯聚己内酯(PCL)作为合成材料的参考,评估了B细胞对植入肌肉伤口的生物材料的反应。在局部肌肉组织中,少量B细胞因组织损伤和生物材料植入而出现。ECM材料诱导淋巴结中的成熟B细胞以及脾脏中的抗原呈递。合成PCL植入物导致伤口中B细胞的存在时间延长,并诱导出抗原呈递表型。总之,B细胞对生物材料的适应性免疫反应会引发局部、区域和全身的免疫变化。
Adv Drug Deliv Rev. 2017-7-13
Proc Natl Acad Sci U S A. 2025-5-20
Matrix Biol Plus. 2025-3-23
Cell Stem Cell. 2025-5-1
Bioact Mater. 2024-8-9
Acta Biomater. 2024-8
Adv Wound Care (New Rochelle). 2025-3
Adv Healthc Mater. 2025-2
Trends Immunol. 2020-7
Annu Rev Pathol. 2019-11-1
J Clin Invest. 2019-8-13
Front Immunol. 2019-4-5
Sci Rep. 2019-2-6